What are the management options for erectile dysfunction (ED)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Erectile dysfunction (ED) can be effectively managed through a combination of lifestyle modifications and medical treatments, with first-line treatment typically involving oral phosphodiesterase type 5 (PDE5) inhibitors such as sildenafil, tadalafil, vardenafil, or avanafil, as recommended by the American College of Physicians 1. The management of ED should prioritize addressing underlying causes, including controlling diabetes, hypertension, and high cholesterol; quitting smoking; reducing alcohol consumption; maintaining a healthy weight; and regular exercise, as these factors can significantly improve erectile function 1. Psychological factors like stress, anxiety, and depression should also be addressed, potentially through counseling or therapy, as they can contribute to ED 1. Testosterone replacement may be beneficial if low testosterone is confirmed through blood tests, although the American College of Physicians does not recommend routine use of hormonal blood tests or hormonal treatment in the management of patients with ED due to insufficient evidence 1. Patients should discuss their complete medical history and medication list with their doctor, as certain conditions and medications can contribute to ED or interact with ED treatments. For patients who don't respond to oral medications, second-line options include vacuum erection devices, intracavernosal injections with medications like alprostadil, or intraurethral suppositories, and referral to a urologist or sexual health specialist may be warranted to review these treatment options 1. It is essential to note that the choice of a specific PDE-5 inhibitor should be based on the individual preferences of men with ED, including ease of use, cost of medication, and adverse effects profile, as recommended by the American College of Physicians 1. Overall, a comprehensive approach to managing ED should consider both medical and lifestyle factors to improve erectile function and overall quality of life.

From the FDA Drug Label

Tadalafil tablets are a prescription medicine taken by mouth for the treatment of: men with erectile dysfunction (ED) Tadalafil tablets helps increase blood flow to the penis and may help men with ED get and keep an erection satisfactory for sexual activity. Vardenafil has not been evaluated in patients with severe hepatic impairment (Child-Pugh C) The safety and efficacy of LEVITRA used in combination with other treatments for erectile dysfunction have not been studied.

  • Management options for erectile dysfunction (ED) include:
    • Phosphodiesterase type 5 (PDE5) inhibitors such as tadalafil and vardenafil
    • Lifestyle modifications (not mentioned in the provided drug labels)
    • Other treatments (not mentioned in the provided drug labels)
  • Key considerations:
    • PDE5 inhibitors should be used with caution in patients with certain medical conditions, such as heart problems, low blood pressure, and liver or kidney impairment
    • Patients should be advised to contact their healthcare provider if they experience any unwanted effects or if they are not satisfied with the quality of their sexual performance
    • PDE5 inhibitors should not be used in combination with nitrates or guanylate cyclase stimulators, as this can cause a sudden drop in blood pressure 2, 2, 3

From the Research

Management Options for Erectile Dysfunction (ED)

The management of ED involves a range of options, including:

  • Lifestyle modifications, such as tobacco cessation, regular exercise, weight loss, and improved control of diabetes, hypertension, and hyperlipidemia 4, 5
  • Pharmacotherapy, including phosphodiesterase type 5 inhibitors (PDE5i) such as sildenafil, tadalafil, vardenafil, and avanafil, which are effective in 60-65% of men with ED, including those with comorbid medical conditions 6, 7
  • Patient-administered intracorporal injection therapy using vasodilator drugs such as alprostadil, which is an effective treatment for men who fail to respond to oral pharmacological agents 6
  • Surgical treatment, including multicomponent inflatable penile implants, which are associated with high satisfaction rates, and penile arterial revascularisation and venous ligation surgery, which have relatively poor outcome results 6
  • Alternative therapeutic options, such as vacuum pump devices, intraurethral suppositories, and surgically implanted penile prostheses, which may be considered when other treatments have been ineffective 8, 4, 5
  • Novel therapies, including shock-wave therapy, external prosthetic devices, and injection of stem cells or platelet-rich plasma, which are currently being developed and may eventually alter the treatment paradigm for ED 8

First-Line Treatments

First-line treatments for ED typically include:

  • Oral phosphodiesterase-5 inhibitors, which are the most effective oral drugs for treatment of ED 4, 5, 7
  • Lifestyle changes, such as modifying drug therapy that may cause ED, and counseling for men with psychogenic ED 4, 5

Second-Line Treatments

Second-line treatments for ED may include:

  • Alprostadil, which can be administered via intraurethral or intracavernosal injection 4, 5
  • Vacuum devices, which can be used to assist with achieving an erection 4, 5
  • Surgically implanted penile prostheses, which may be considered when other treatments have been ineffective 4, 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Erectile Dysfunction.

American family physician, 2016

Research

Management of erectile dysfunction.

American family physician, 2010

Research

Current diagnosis and management of erectile dysfunction.

The Medical journal of Australia, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.